| Literature DB >> 36211774 |
Abstract
Fermentum is a common unicellular fungus with many biological activities attributed to β-polysaccharides. Different in vivo and in vivo experimental studies have long proven that fermentum β-polysaccharides have antioxidant, anti-tumor, and fungal toxin adsorption properties. However, there are many uncertainties regarding the relationship between the structure and biological activity of fermentum β-polysaccharides, and a systematic summary of fermentum β-polysaccharides is still lacking. Herein, we reviewed the research progress about the extraction, structure and modification, structure-activity relationship, activity and application of fermentum β-polysaccharides, compared the extraction methods of fermentum β-polysaccharide, and paid special attention to the structure-activity relationship and application of fermentum β-polysaccharide, which provided a strong basis for the development and application of fermentum β-polysaccharide.Entities:
Keywords: Activity; Application; Extraction; Fermentum β-polysaccharides; Modification; Structure–activity relationship
Year: 2022 PMID: 36211774 PMCID: PMC9532711 DOI: 10.1016/j.fochx.2022.100388
Source DB: PubMed Journal: Food Chem X ISSN: 2590-1575
Fig. 1The cell wall of Fermentum.
Structure-Activity Relationship of Fermentum β-polysaccharide.
| Compound name | Molecular weight | Structure/Construction | Purity | biological activity | Experimental model | Mechanism | References |
|---|---|---|---|---|---|---|---|
| BYGlc | 25 kDa | Linear β-(1 → 3)-polysaccharide | 99% | Hypoglycemic | Diabetic mice | Inhibits the expression of SGLT-1 in the intestinal mucosa and significantly reduces blood sugar, promotes glycogen synthesis, inhibits hepatic fat accumulation, inhibits macrophage infiltration and the production of pro-inflammatory cytokines | ( |
| YG2-21 | 2496 kDa | β- | Regulate immunity | Macrophages | Induced expression in RAW264.7 cells | ( | |
| sGSC1 | 12.9 kDa | β- | Antioxidants regulate immunity | Mouse | Decreases malondialdehyde (MDA) levels; promotes the secretion of IL-2 and IFN-γ, and increases the CD4+/CD8 + ratio of lymphocytes | ( | |
| β-polysaccharide | 27.9 kDa | Linearly linked β-d-glucopyranosyl units with (1 → 3) and (1 → 6) linkages | 91% | Anti-oxidation | In vitro test | ( | |
| BCS004 | 689.351 kDa | Linear configuration containing (1–6)-branched (1–3)-β- | 90% | Anti-oxidation | In vitro test | ( | |
| sGSC3 | 19.2 kDa | β- | Antioxidants regulate immunity | Mouse | Decreases malondialdehyde (MDA) levels; promotes the secretion of IL-2 and IFN-γ, and increases the CD4+/CD8 + ratio of lymphocytes | ( | |
| BYG | Rod-like structures of native triplex and nanoparticle-like substructures | 85.3% | Anti-inflammatory | Colitis mice | Inhibition of oxidative stress (NO, MDA, and MPO) ameliorates inflammation in a DSS-induced colitis mouse model | ( | |
| YG2-32 | 1335 kDa | β- | Regulate immunity | Macrophages | Induced expression in RAW264.7 cells | ( | |
| sGSC2 | 16.5 kDa | β- | Antioxidants regulate immunity | Mouse | Decreases malondialdehyde (MDA) levels; promotes the secretion of IL-2 and IFN-γ, and increases the CD4+/CD8 + ratio of lymphocytes | ( | |
| β-polysaccharide | With β-glycosidic bonds, (1–3)-β-polysaccharide chains form a triple helix three-dimensional structure | Antibacterial, anticancer | A549 human lung cancer cells, MDA-MB-231 human breast cancer cells, HePG-2 human liver cancer cells | Induces apoptosis of cancer cells, and highly induces TNFα, IL-6, IFN-γ and IL-2 to play an immunoregulatory role | ( | ||
| BBG1 | Highly branched beta-(1,6) polysaccharide | Anti-inflammatory | Mouse colon | Reduces pro-inflammatory mediators of IL-6, iNOS and IL-1β at protein and mRNA levels | ( | ||
| BBG2 | Linear β-(1,3)-polysaccharide | Anti-inflammatory | Mouse colon | Reduces pro-inflammatory mediators of IL-6, iNOS and IL-1β at protein and mRNA levels | ( | ||
| BBG3 | A mixture of β-(1,6) branched β-(1,3)-polysaccharides and linear β-(1,3)-polysaccharides | Anti-inflammatory | Mouse colon | Reduces pro-inflammatory mediators of IL-6, iNOS and IL-1β at protein and mRNA levels | ( | ||
| BBG4 | A mixture of β-(1,6) branched β-(1,3)-polysaccharides and linear β-(1,3)-polysaccharides | Anti-inflammatory | Mouse colon | Reduces pro-inflammatory mediators of IL-6, iNOS and IL-1β at protein and mRNA levels | ( | ||
| P-PJ | (1 → 3)- | Anti-oxidation | In vitro test | ( | |||
| CM-PJ | (1 → 3)- | Anti-oxidation | In vitro test | ( | |||
| CS-PJ | (1 → 3)- | Anti-oxidation | In vitro test | ( | |||
| WYG-1 | 3700 kDa | Confirmation is spherical, highly branched | ( | ||||
| WYG-2 | 2830 kDa | Confirmation is spherical, highly branched | ( | ||||
| WYG-3 | 1320 kDa | Confirmation is spherical, highly branched | ( | ||||
| WYG-4 | 172.5 kDa | Has a triple helix structure and rigid chain | ( | ||||
| WYG-5 | 54.5 kDa | Has a triple helix structure and rigid chain | ( | ||||
| SBG | 1,6-linked branched chain with regular comb-like branches, triple helix structure | ( |
Fig. 2Structure of Fermentum β-polysaccharide.
Fig. 3Fermentum β-polysaccharide pattern recognition receptor and its effects (Brown and Gordon, 2005, De Marco Castro et al., 2021).
Fig. 4Intestinal regulation of Fermentum β-polysaccharide.
Fig. 5The protective mechanism of Fermentum β-polysaccharide on skin.